Ligand validation:7JXA

I3P: D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE

I3P is a Ligand Of Interest in 7JXA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7JXA_I3P_A_501	71%	61%	0.113	0.934	0.83	0.65	1	-	0	0	100%	1
7JXA_I3P_C_501	63%	68%	0.147	0.943	0.69	0.56	-	-	0	0	100%	1
7JXA_I3P_D_501	26%	70%	0.198	0.836	0.62	0.55	-	-	0	0	100%	0.75
7JXA_I3P_B_501	17%	62%	0.206	0.787	0.86	0.59	1	-	0	0	100%	0.75
7F1X_I3P_D_501	58%	50%	0.143	0.92	1.31	0.63	3	-	0	0	100%	1
2P0D_I3P_A_800	98%	50%	0.063	0.982	0.78	1.15	-	5	0	0	100%	1
8T8Y_I3P_A_404	96%	33%	0.08	0.99	1.29	1.37	3	7	1	0	100%	1
3V0H_I3P_A_1	94%	55%	0.076	0.977	0.76	0.98	-	2	1	0	100%	1
1H0A_I3P_A_1164	94%	22%	0.079	0.978	1.58	1.65	4	10	0	0	100%	1
1DJX_I3P_B_1	90%	48%	0.084	0.966	0.9	1.12	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.